Christoph U. Correll, MD

Christoph U. Correll, MD, is a professor of psychiatry and molecular medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY. He is also a professor and chair of the Department of Child and Adolescent Psychiatry, Charité - University Medicine Berlin, Germany. Dr Correll completed his medical studies at the Free University of Berlin in Germany and the University of Dundee School of Medicine in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at Zucker Hillside Hospital in Glen Oaks, NY. He has been working and conducting research in the United States since 1997 and in Germany since 2017.

Dr Correll focuses on the identification and treatment of youths and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-analyses, and the interface between physical health and mental health. He has authored or coauthored more than 900 journal articles that have been cited more than 81,000 times, and he has received more than 40 research awards for his work. In June 2024, his h-index was 145 in Google Scholar, with an h-index of greater than 100 in the last 5 years alone.

Since 2014, the beginning of this metric, Dr Correll has been listed every year by Clarivate and Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry.” Additionally, he has been holding numerous Expertscape rankings based on his number of publications and citations in the past 10 years (ie, for 15 topics as “Expert” [among the top 1% cited scientists] and for 24 topics as “World Expert” [among the top 0.1% cited scientists]), including in June 2024 when he was ranked as number 1 among world experts for the following areas: central nervous system depressants (out of 259,989 ranked scientists); psychotropic drugs (out of 138,731 scientists); schizophrenia (out of 101,038 scientists); schizophrenia spectrum and other psychotic disorders (out of 121,673 scientists); antipsychotics (out of 56,247 scientists); delayed action preparations (out of 69,531 scientists); tranquilizing agents (out of 72,377 scientists); and weight gain (out of 76,380 scientists).